Eli Lilly takes weight-loss pill battle global with first Foundayo approval outside U.S.

Eli Lilly's drug, Foundayo, has won approval in the U.K., extending its participation in the weight-loss pill battle beyond the U.S. market. This development intensifies the competition between Eli Lilly and Novo Nordisk regarding their respective treatments.